Latest filing published 29 Jun 2016 for Cartesian Therapeutics, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +42.0%Entry US$419.70 · Close at T+365 US$595.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Nanodimension Management Ltd: trading record in brief
This profile gathers the share dealings of Nanodimension Management Ltd in Cartesian Therapeutics, Inc. Altogether 2 filings, all relating to 27 June 2016.
No open-market sale appears; the market trades are 1 purchase worth €4.9M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The newest entry dates from 29 June 2016: a transaction, in Cartesian Therapeutics, Inc. The last purchase on record was published on 29 June 2016, which is 3,785 days ago. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Nanodimension Management Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 637,790 shares0Common StockSEC:0001104659-16-130147:0
- 385,000 shares@ US$14.00100.0% of flowCommon StockSEC:0001104659-16-130147:1Canonical exit: 25 Sept 2016 (T+90)
2 of 2 declarations
